{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:20:45Z","timestamp":1792272045090,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jocn.2021.02.016","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T03:37:32Z","timestamp":1615520252000},"page":"44-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The therapeutic effects of ginkgolides in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis"],"prefix":"10.1016","volume":"87","author":[{"given":"Chunrong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaolifan","family":"Aerqin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangding","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jocn.2021.02.016_b0005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1586\/1744666X.2013.811119","article-title":"Infectious and noninfectious triggers in Guillain-Barr\u00e9 syndrome","volume":"9","author":"Wakerley","year":"2013","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.jocn.2021.02.016_b0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","article-title":"Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barr\u00e9 syndrome","volume":"84","author":"Zhu","year":"1998","journal-title":"J Neuroimmunol"},{"issue":"13","key":"10.1016\/j.jocn.2021.02.016_b0015","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/anie.200300601","article-title":"Chemistry and biology of terpene trilactones from Ginkgo biloba","volume":"43","author":"Str\u00f8mgaard","year":"2004","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"10.1016\/j.jocn.2021.02.016_b0020","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0006-291X(89)92107-4","article-title":"Effect of cyclosporin A and the platelet-activating factor (PAF) antagonist, BN 52021, on PAF- and antigen-induced bronchoconstriction in the guinea-pig","volume":"163","author":"Touvay","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.jocn.2021.02.016_b0025","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1523\/JNEUROSCI.1171-15.2016","article-title":"Platelet-activating factor receptors mediate excitatory postsynaptic hippocampal injury in experimental autoimmune encephalomyelitis","volume":"36","author":"Bellizzi","year":"2016","journal-title":"J Neurosci"},{"issue":"8093","key":"10.1016\/j.jocn.2021.02.016_b0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.jocn.2021.02.016_b0035","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barr\u00e9 syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.jocn.2021.02.016_b0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0887-8994(96)00050-1","article-title":"Severe Guillain-Barr\u00e9 syndrome in childhood treated with human immune globulin","volume":"14","author":"Reisin","year":"1996","journal-title":"Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.jocn.2021.02.016_b0045","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","article-title":"Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis","volume":"24","author":"Zhang","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.jocn.2021.02.016_b0050","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/260473","article-title":"IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barr\u00e9 syndrome","volume":"2012","author":"Li","year":"2012","journal-title":"Mediators Inflamm"},{"issue":"9","key":"10.1016\/j.jocn.2021.02.016_b0055","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jocn.2007.09.016","article-title":"Increased levels of activated T-cells and reduced levels of CD4\/CD25+ cells in peripheral blood of Guillain-Barr\u00e9 syndrome patients compared to controls","volume":"15","author":"Harness","year":"2008","journal-title":"J Clin Neurosci"},{"issue":"4","key":"10.1016\/j.jocn.2021.02.016_b0060","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejps.2012.07.016","article-title":"Inhibition of NF-\u03baB activation is associated with anti-inflammatory and anti-apoptotic effects of Ginkgolide B in a mouse model of cerebral ischemia\/reperfusion injury","volume":"47","author":"Gu","year":"2012","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.jocn.2021.02.016_b0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-014-0167-6","article-title":"Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1\/2 and p38 MAPK activation","volume":"11","author":"Jiang","year":"2014","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.jocn.2021.02.016_b0070","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s12192-016-0728-y","article-title":"Ginkgolides and bilobalide protect BV2 microglia cells against OGD\/reoxygenation injury by inhibiting TLR2\/4 signaling pathways","volume":"21","author":"Zhou","year":"2016","journal-title":"Cell Stress Chaperones"},{"issue":"2","key":"10.1016\/j.jocn.2021.02.016_b0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1254\/jphs.94.129","article-title":"In vitro effects of astaxanthin combined with ginkgolide B on T lymphocyte activation in peripheral blood mononuclear cells from asthmatic subjects","volume":"94","author":"Mahmoud","year":"2004","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.jocn.2021.02.016_b0080","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3340\/jkns.2016.1010.018","article-title":"Ginkgolide B modulates BDNF expression in acute ischemic stroke","volume":"60","author":"Wei","year":"2017","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"10.1016\/j.jocn.2021.02.016_b0085","first-page":"151","article-title":"Bilobalide promotes expression of glial cell line-derived neurotrophic factor and vascular endothelial growth factor in rat astrocytes","volume":"21","author":"Zheng","year":"2000","journal-title":"Acta Pharmacol Sin"},{"issue":"1\u20132","key":"10.1016\/j.jocn.2021.02.016_b0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2012.02.011","article-title":"IFN-\u03b3 deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response","volume":"246","author":"Zhang","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jocn.2021.02.016_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/758639","article-title":"Role of cytokines and Toll-like receptors in the immunopathogenesis of Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Nyati","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.jocn.2021.02.016_b0100","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.3892\/mmr.2015.3730","article-title":"Toll-like receptor 2 and -4 are involved in the pathogenesis of the Guillain-Barr\u00e9 syndrome","volume":"12","author":"Du","year":"2015","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.jocn.2021.02.016_b0105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuroscience.2008.12.034","article-title":"Toll-like receptor-2, CD14 and heat-shock protein 70 in inflammatory lesions of rat experimental autoimmune neuritis","volume":"159","author":"Zhang","year":"2009","journal-title":"Neuroscience"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821000898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586821000898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:24:28Z","timestamp":1760822668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586821000898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":21,"alternative-id":["S0967586821000898"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2021.02.016","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The therapeutic effects of ginkgolides in Guillain-Barr\u00e9 syndrome and experimental autoimmune neuritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2021.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}